Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

41.77
+0.08000.19%
Post-market: 41.900.1300+0.31%19:30 EDT
Volume:61.84K
Turnover:2.58M
Market Cap:284.04M
PE:- -
High:41.83
Open:41.75
Low:41.21
Close:41.69
52wk High:41.86
52wk Low:22.33
Shares:6.80M
Float Shares:6.80M
Volume Ratio:0.33
T/O Rate:0.91%
Dividend:0.28
Dividend Rate:0.67%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Electra Therapeutics indicated to open at $20, IPO priced at $15

TIPRANKS
·
Sep 18

LIVE Markets-Cash-Return Stocks Win Back Investor Favor, Leaving Megacaps Behind

Reuters
·
Sep 18

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
Sep 18

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

TIPRANKS
·
Sep 18

Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential

TIPRANKS
·
Sep 18

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Sep 18

Incyte R&D President Pablo J. Cagnoni Disposes of 23,218 Common Shares Worth $2.8 Million

Reuters
·
Sep 18

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
Sep 18

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Sep 18

Moderna Inc Stock (MRNA) Moved Up by 7.25% on Sep 17: Facts Behind the Movement

TradingKey
·
Sep 18

Longeveron Stock (LGVN) Plummets 56% on a Failed Clinical Trial

TIPRANKS
·
Sep 18

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Dow Jones
·
Sep 18

Moderna Shares Hit Four-Week High; Last up 8%

THOMSON REUTERS
·
Sep 17

Twist Bioscience Price Target Raised to $160.00/Share from $120.00 by Leerink Partners

Dow Jones
·
Sep 17

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Twist Bioscience (TWST) and Medpace Holdings (MEDP)

TIPRANKS
·
Sep 17

Hemab Therapeutics doses first patient in HMB-003 trial

TIPRANKS
·
Sep 17

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Sep 17

Fennec presents results from STS-J01 clinical trial evaluating Pedmark

TIPRANKS
·
Sep 17

Twist Bioscience Corporation : Leerink Partners Raises Target Price to $160 from $120

THOMSON REUTERS
·
Sep 17

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Dow Jones
·
Sep 17